GALECTIN THERAPEUTICS INC — Director's Dealing 2013

Mar 11, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2013-03-07

Reporting Person: ROME JERALD K (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-03-07	Common Stock	M	2500	$2.28	Acquired	22058	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-03-07	Employee Stock Option (right to buy)	$2.28	M	2500	Disposed	2013-03-13	Common Stock (2500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	7002	Indirect

Footnotes

F1: The Company effected a 1-for-6 reverse stock split in March 2012, resulting in a corresponding reduction in the number of shares of common stock owned by the reporting person.

F2: This option was previously reported as covering 15,000 shares at an exercise price of $0.38 per share, but was adjusted to reflect the 1-for-6 reverse stock split that occurred in March 2012.